“Drug development in psychiatry: 50 years of failure and how to resuscitate it”
This opinion by Professor David Nutt was published in Lancet Psychiatry, 11 February 2025: Table 1: Table 2:
Tag: Paid opinion leaders
The Myth of Unbiased Medical Education
In a recent blog I shared promotional material hosted by the BMJ. This material included videos of a symposium held at the Royal Society of Medicine: The Royal Society of … Continue reading The Myth of Unbiased Medical Education
2024 Psychopharmacology Committee of RCPsych: transparency at an all time low.
Over the last decade I have looked at the governance of the Psychopharmacology Committee of the Royal College of Psychiatrists. My hope was to find improvement in relation to transparency. … Continue reading 2024 Psychopharmacology Committee of RCPsych: transparency at an all time low.
Clarifying deprescribing
A published response by Niall McLaren to an Editorial by Jeffrey CL Looi et al:
Deprescribing antidepressants
A published response by Mark Horowitz and David Taylor to an Editorial by Jeffrey CL Looi et al: Another published response by Niall McLaren to the Editorial by Jeffrey CL … Continue reading Deprescribing antidepressants
Light breaks where no sun shines
On The BMJ home page I came across this advert by Eli Lilly. It invited me to “Learn how to better identify early signs of Alzheimer’s Disease” and warned that … Continue reading Light breaks where no sun shines
‘Moving towards zero tolerance’
BMJ, 19 November 2024: Response by Amit Aggarwal, Executive Director Medical Affairs & Strategic Partnerships, The Association of the British Pharmaceutical Industry (ABPI): Dr Peter J Gordon and Dr Sian … Continue reading ‘Moving towards zero tolerance’
Neuromarket
Neuromarket ‘Street drugs’, – desire and despair – have a new market.